Operating Income: The income after operating expenses.
Aridis Pharmaceuticals (ARDS) had Operating Income of $-0.87M for the most recently reported fiscal quarter, ending 2023-09-30.
| Income Statement Financials | |
$0.42M |
|
$-0.08M |
|
-- |
|
$0.42M |
|
$1.29M |
|
|
Operating Income |
$-0.87M |
$0.79M |
|
$-0.08M |
|
$-0.08M |
|
$-0.08M |
|
$-0.08M |
|
$-0.08M |
|
$-0.08M |
|
$-0.87M |
|
$-0.81M |
|
37.43M |
|
37.43M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$4.11M |
|
$0.51M |
|
$2.42M |
|
$6.53M |
|
$17.48M |
|
-- |
|
$0.85M |
|
$18.34M |
|
$-11.80M |
|
$-11.81M |
|
$-11.80M |
|
44.57M |
|
| Cash Flow Statement Financials | |
$-9.33M |
|
$0.01M |
|
$4.29M |
|
$5.56M |
|
$0.54M |
|
$-5.02M |
|
$0.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.24 |
|
-- |
|
-- |
|
-- |
|
-0.29 |
|
100.00% |
|
-208.39% |
|
-208.39% |
|
-- |
|
-19.90% |
|
-19.90% |
|
$-9.31M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
0.81 |
|
111.58 |
|
0.70% |
|
0.70% |
|
-1.27% |
|
0.70% |
|
$-0.26 |
|
$-0.25 |
|
$-0.25 |
|